Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Net Margin (2025 - 2026)

Kura Oncology has reported Net Margin over the past 2 years, most recently at 401.49% for Q1 2026.

  • Quarterly Net Margin rose 557.0% to 401.49% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 22.61% through Mar 2026, changed N/A year-over-year, with the annual reading at 0.44% for FY2025, 32245.0% up from the prior year.
  • Net Margin was 401.49% for Q1 2026 at Kura Oncology, down from 1138.5% in the prior quarter.
  • Over five years, Net Margin peaked at 1138.5% in Q4 2025 and troughed at 432.51% in Q2 2025.